title: First Report on Infant Acute Urticaria after Mother's Parenteral Use of Meglumine Antimoniate (Glucantime): A Case Report.
abstract: Pentavalent antimonials are still the first drug of choice for the treatment of cutaneous leishmaniasis (CL). Like other treatments, they can cause adverse reactions including musculoskeletal pain, gastrointestinal disturbances, and mild to moderate headaches. In this paper, we report the first case of an infant who developed acute urticaria after her mother's parenteral use of meglumine antimoniate (glucantime).
authors.affiliation: Dept. of Traditional Persian Medicine, School of Medicine, Student Research Committe, Mazandaran University of Medical Sciences, Sari, Iran; Dept. of Traditional Persian Medicine, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
authors.forename: Omid
authors.initials: O
authors.lastname: Mozafari
authors.affiliation: Traditional and Complementary Medicine Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
authors.forename: Seyed Afshin
authors.initials: SA
authors.lastname: Shorofi
authors.affiliation: Traditional and Complementary Medicine Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
authors.forename: Seyde Sedighe
authors.initials: SS
authors.lastname: Yousefi
keywords: Adverse reactions; Cutaneous leishmaniasis; Meglumine antimoniate (Glucantime)